Peer-reviewedCC BY-NC-NDInternal Medicine
Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid Therapy
Abstract
An 81-year-old Japanese man with IgG4-related disease (IgG4-RD) presented with marked edema in the right lower leg. He was diagnosed with IgG4-RD with retroperitoneal fibrosis, hilar and mediastinal lymphadenopathy, elevated serum IgG4 levels, and IgG4-positive plasma cell infiltration in a mediastinal lymph node. Lymphatic scintigraphy revealed an obstruction corresponding to edema due to retroperitoneal fibrosis. Glucocorticoid therapy resulted in rapid improvement. Lymphedema due to IgG4-RD with retroperitoneal fibrosis is rare and no standard treatment exists. This case underscores the importance of considering IgG4-RD which is a potentially reversible cause of lymphedema.
Related
- Greater and Clinically Meaningful Improvement in Health-Related Quality of Life After Device-Aided Therapy in Younger Patients Earlier Within Advanced Parkinson’s Disease: Real-World Evidence from the DATs-PD GETM Spanish Registry
- Recurrent Cellulitis in Lymphedema: Integrating Antibiotic Prophylaxis, Conservative Therapy, Local Disease Control, and Lymphaticovenular Anastomosis.
- Early-onset medication-related osteonecrosis of the jaw in adolescents with Duchenne muscular dystrophy receiving long-term antiresorptive combined with glucocorticoid therapy: Two case reports
- Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy
- Pixel-Level Quantification of Subcutaneous Shear-Wave Velocity Heterogeneity for Grading Lymphatic Obstruction in Breast Cancer-Related Lymphedema
BibTeX
@article{matsushita2026improvement,
title = {{Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid Therapy}},
author = {Yuta Matsushita and Masataka Umeda and Hirokazu Kurohama and Tomoki Origuchi and Kanako Kojima and Yoshika Tsuji and Remi Sumiyoshi and Naoki Iwamoto and Atsushi Kawakami},
journal = {Internal Medicine},
year = {2026},
month = aug,
doi = {10.2169/internalmedicine.6044-25},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/15/65_6044-25/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid Therapy
AU - Yuta Matsushita
AU - Masataka Umeda
AU - Hirokazu Kurohama
AU - Tomoki Origuchi
AU - Kanako Kojima
AU - Yoshika Tsuji
AU - Remi Sumiyoshi
AU - Naoki Iwamoto
AU - Atsushi Kawakami
PY - 2026
DA - 2026/08/01
JO - Internal Medicine
DO - 10.2169/internalmedicine.6044-25
UR - https://www.jstage.jst.go.jp/article/internalmedicine/65/15/65_6044-25/_article
AB - An 81-year-old Japanese man with IgG4-related disease (IgG4-RD) presented with marked edema in the right lower leg. He was diagnosed with IgG4-RD with retroperitoneal fibrosis, hilar and mediastinal lymphadenopathy, elevated serum IgG4 levels, and IgG4-positive plasma cell infiltration in a mediastinal lymph node. Lymphatic scintigraphy revealed an obstruction corresponding to edema due to retroperitoneal fibrosis. Glucocorticoid therapy resulted in rapid improvement. Lymphedema due to IgG4-RD with retroperitoneal fibrosis is rare and no standard treatment exists. This case underscores the importance of considering IgG4-RD which is a potentially reversible cause of lymphedema.
SN - 1349-7235
SN - 0918-2918
ER -